Company Valuation: Astal Laboratories Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2020 2021 2022 2023 2024 2025
Market Cap 1 36.52 34.77 64.34 118.1 401.9 747.2
Change - -4.79% 85.03% 83.54% 240.29% 85.93%
Enterprise Value (EV) 1 36.38 34.46 64.16 117.2 344.2 862.6
Change - -5.27% 86.18% 82.75% 193.57% 150.59%
P/E -130x 577x -376x 722x 26.3x 9.45x
PBR 0.71x 0.67x 1.25x 2.27x 1.72x 2.08x
PEG - -5x 1x -4x 0x 0x
Capitalization / Revenue 18.1x 17.2x 30.5x 3.27x 1.7x 1.17x
EV / Revenue 18x 17.1x 30.4x 3.25x 1.45x 1.36x
EV / EBITDA - - - - - -
EV / EBIT - - - - - -
EV / FCF - - - - - -
FCF Yield - - - - - -
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -0.0708 0.0152 -0.0431 0.041 1.554 8.043
Distribution rate - - - - - -
Net sales 1 2.019 2.019 2.108 36.07 236.6 636.6
EBITDA - - - - - -
EBIT - - - - - -
Net income 1 -0.2815 0.0602 -0.1711 0.164 7.847 89.25
Net Debt 1 -0.1448 -0.3129 -0.1828 -0.844 -57.64 115.4
Reference price 2 9.19 8.75 16.19 29.60 40.88 76.01
Nbr of stocks (in thousands) 3,974 3,974 3,974 3,990 9,830 9,830
Announcement Date 10/09/20 01/09/21 08/09/22 25/08/23 12/07/24 18/08/25
1INR in Million2INR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 3.68Cr
33.01x11.99x24.31x0.6% 1,03400Cr
30.97x - - 1.93% 67TCr
33.21x7.7x16x2.64% 46TCr
19.86x4.73x11.71x2.8% 35TCr
23.09x5.93x14.7x2.69% 31TCr
21.15x4.34x12.39x2.03% 26TCr
28.09x7.23x12.82x2.27% 24TCr
13.44x4.86x10.14x3.75% 21TCr
-46.21x6.66x25.99x2.18% 19TCr
Average 17.40x 6.68x 16.01x 2.32% 37.17TCr
Weighted average by Cap. 24.37x 8.05x 17.85x 1.94%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. MACINTR Stock
  4. Valuation Astal Laboratories Limited